CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 29.84
-2.20 (-6.87%)
Apr 29, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 12.90 billion as of April 29, 2026. Its market cap has increased by 5.34% in one year.
Market Cap
12.90B
Enterprise Value
11.39B
Revenue
1.19B
Ranking
n/a
PE Ratio
261.75
Stock Price
29.84
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 12.90B, an increase of 70.38%. That is a compound annual growth rate of 7.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Consun Pharmaceutical Group | 13.24B |
| Xuanzhu Biopharmaceutical | 12.59B |
| Sihuan Pharmaceutical Holdings Group | 11.94B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Luye Pharma Group | 10.75B |
| Shandong Xinhua Pharmaceutical Company | 9.47B |
| The United Laboratories International Holdings | 18.82B |
| China Traditional Chinese Medicine Holdings Co. | 8.61B |